.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
US Department of Justice
QuintilesIMS
Cipla
Accenture
Mallinckrodt
Medtronic
Express Scripts
Fish and Richardson
McKesson

Generated: September 20, 2017

DrugPatentWatch Database Preview

M.V.I. ADULT Drug Profile

« Back to Dashboard

Which patents cover M.v.i. Adult, and when can generic versions of M.v.i. Adult launch?

M.v.i. Adult is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in M.V.I. ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k profile page.

Summary for Tradename: M.V.I. ADULT

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E','VITAMIN K') AND hsdb_d' at line 1
Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Clinical Trials: see list7,718